Collagen Filler Market Size to Exceed USD 924.0 Mn by 2032

The Collagen Filler Market, estimated at USD 560.6 Mn in 2025, is expected to exhibit a CAGR of 7.4% and reach USD 924.0 Mn by 2032.

The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.

Increasing adoption of strategies by key market players like collaboration is expected to drive the global collagen filler market growth over the forecast period. For instance, on April 4, 2023, Stratasys, a Israel- based additive manufacturing company, and CollPlant Biotechnologies Ltd., a Israel based biotechnology company, announced joint development and commercialization agreement for the development of CollPlant’s rh-Collagen-based bioinks and commercialization of bioink products. This focuses on the development of an industrial-scale solution for CollPlant's regenerative implants program. Under the agreement, both companies agreed to promote bioprinting products. Stratasys’ bioprinter will be offered to customers together with CollPlant’s bioinks, and similarly Stratasys’ bioprinter will be offered to CollPlant’s business partners and customers.

Global Collagen Filler Market – Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others faced problems regarding transportation of drugs from one place to another.

COVID-19 had negative impact on the global collagen filler market due to the side effects associated with the fillers. Due to vaccination, several side effects like hypersensitivity reactions were observed due to interaction of vaccine with collagen fillers. For instance, according to an article published in Canadian journal of emergency medicine, on March 16, 2022, delayed inflammatory reactions to dermal fillers was observed in response to mRNA COVID-19 vaccine by Moderna Inc., a U.K.-based pharmaceutical and biotechnology company.

Global Collagen Filler Market: Key Developments

Increasing collaboration between key market players is expected to drive the market growth.

For instance, on February 22, 2021, Allergan Aesthetics, an AbbVie company, a Ireland- based pharmaceutical company, announced that it had entered into an exclusive development and commercialization agreement with regenerative medicine company CollPlant Biotechnologies Ltd., a Israel- based biotechnology company, to use its plant-derived recombinant human collagen. Allergan stated that the collagen (rhCollagen) will be used  for the production and commercialization of dermal and soft tissue fillers. CollPlant Biotechnologies Ltd.'s rhCollagen is non-immunogenic and non-allergenic that offers better tissue regeneration performance over animal-derived collagen, and is currently used in medical aesthetics. This agreement further validates CollPlant Biotechnologies Ltd's technology as the gold standard collagen for regenerative and aesthetic medicine.

Browse 39 Market Data Tables and 38 Figures spread through 160 Pages and in-depth TOC on Global Collagen Filler Market, By Product Type (Collagen with PMMA and Collagen without PMMA), By Source (Bovine, Porcine, and Others), By Application (Face Rejuvenation, Wrinkles, Scar Treatment, Lip Treatment, Cellulite Reduction, and Others), By End User (Hospitals, Dermatology Clinics, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/collagen-filler-market-4209

Key Takeaways of the Global Collagen Filler Market:

• Global collagen filler market is expected to exhibit a CAGR of 7.4% during the forecast period. Funding raised by the key market players is expected to accelerate its research and development activities. For instance, on June 26, 2023, CollPlant Biotechnologies Ltd., a Israel- based biotechnology company, received US$ 10 million funding for developing a regenerative dermal and soft tissue filler product as a part of an agreement with AbbVie, a Ireland- based pharmaceutical company with achievement of milestone.
• Among source, bovine segment is expected to dominate the global collagen filler market over the forecast period, owing to launch of new collagen with PMMA. Since, PMMA is a substance made of small synthetic polymer beads suspended in a carrier such as bovine collagen. For instance, on May 14, 2020, Swisse Wellness Pty Ltd., a Australia- based premium quality Vitamins and Supplements provider, announced the launch of Clinical Collagen+ Beauty Blends, the latest addition to the brand’s beauty product range. It is formulated with grass-fed bovine collagen, Verisol Bioactive collagen peptides, hyaluronic acid, and other natural ingredients. The ingredients in Clinical Collagen+ have been shown in clinical studies to improve skin and joint health, and each serving contains ten grams of collagen. The clean-label, non-GMO supplement is formulated to help reduce wrinkles and fine facial lines, increase skin elasticity, and promote healthy aging and smooth skin by supporting collagen and elastin production.
• Among region, North America is expected to be the dominant region in the global collagen filler market, owing to increasing launches or approvals of newer fillers in the region. For instance, on May 5, 2020, GALDERMA, a Switzerland- based pharmaceutical company that specializes in dermatological treatments and skin care products, received the U.S. Food and Drug Administration approval for Restylane Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles around upper lips) in adults over the age of 21. Restylane Kysse is the first filler developed using XpresHAn Technology.
• Major players operating in the global collagen filler market include Allergan, Inc., Johnson & Johnson Private Limited, Collplant Holdings Ltd, Ortho Dermatologics, Inc., Suneva Medical, Inc., Merz Pharma GmbH & Co. KGaA, Surgical Specialties Corporation, Sinclair Pharma, Inamed GmbH, and Endo International plc